Capricor Therapeutics
CAPR
#7992
Rank
ยฃ0.21 B
Marketcap
ยฃ4.76
Share price
-4.36%
Change (1 day)
-59.72%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -ยฃ61.7 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are ยฃ11.13 Million. In 2024 the company made an earning of -ยฃ30.32 Million a decrease over its 2023 earnings that were of -ยฃ16.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ61.7 Million103.53%
2024 -ยฃ30.32 Million81.57%
2023 -ยฃ16.7 Million-23.2%
2022 -ยฃ21.74 Million44.93%
2021 -ยฃ15 Million46.61%
2020 -ยฃ10.24 Million78.71%
2019 -ยฃ5.73 Million-49.7%
2018 -ยฃ11.38 Million-724.78%
2017 ยฃ1.82 M-112.93%
2016 -ยฃ14.09 Million46.27%
2015 -ยฃ9.64 Million106.82%
2014 -ยฃ4.66 Million-48.41%
2013 -ยฃ9.03 Million977.23%
2012 -ยฃ0.84 Million-77.11%
2011 -ยฃ3.67 Million-22.35%
2010 -ยฃ4.72 Million-20.17%
2009 -ยฃ5.91 Million-41.17%
2008 -ยฃ10.04 Million41.05%
2007 -ยฃ7.12 Million1098.87%
2006 -ยฃ0.6 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Cytokinetics
CYTK
-ยฃ0.57 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ12.96 Million-78.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ24.26 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.11 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA